Cited by 58Cancer, Lipids, and MetabolismPeroxisome Proliferator-Activated ReceptorsLipid metabolism and biosynthesis

Novel Effect of C75 on Carnitine Palmitoyltransferase I Activity and Palmitate Oxidation

Bentebibel, Assia, Sebastián, David, Herrero, Laura, López-Viñas, Eduardo, Serra, Dolors, Asins, Guillermina, Gómez-Puertas, Paulino, Hegardt, Fausto G.·2006·Biochemistry

Abstract

C75 is a potential drug for the treatment of obesity. It was first identified as a competitive, irreversible inhibitor of fatty acid synthase (FAS). It has also been described as a malonyl-CoA analogue that antagonizes the allosteric inhibitory effect of malonyl-CoA on carnitine palmitoyltransferase I (CPT I), the main regulatory enzyme involved in fatty acid oxidation. On the basis of MALDI-TOF analysis, we now provide evidence that C75 can be transformed to its C75-CoA derivative. Unlike the activation produced by C75, the CoA derivative is a potent competitive inhibitor that binds tightly but reversibly to CPT I. IC50 values for yeast-overexpressed L- or M-CPT I isoforms, as well as for purified mitochondria from rat liver and muscle, were within the same range as those observed for etomoxiryl-CoA, a potent inhibitor of CPT I. When a pancreatic INS(823/13), muscle L6E9, or kidney HEK293 cell line was incubated directly with C75, fatty acid oxidation was inhibited. This suggests that C75 could be transformed in the cell to its C75-CoA derivative, inhibiting CPT I activity and consequently fatty acid oxidation. In vivo, a single intraperitoneal injection of C75 in mice produced short-term inhibition of CPT I activity in mitochondria from the liver, soleus, and pancreas, indicating that C75 could be transformed to its C75-CoA derivative in these tissues. Finally, in silico molecular docking studies showed that C75-CoA occupies the same pocket in CPT I as palmitoyl-CoA, suggesting an inhibiting mechanism based on mutual exclusion. Overall, our results describe a novel role for C75 in CPT I activity, highlighting the inhibitory effect of its C75-CoA derivative.

Integrity signals

Registry

Crossref · 10.1021/bi052186q

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Pharmacological and genetic inhibition of hypothalamic CPT1A has been reported to reduce food intake.

    “Even so, in the last decade, pharmacological and genetic inhibition of hypothalamic CPT1A has been reported to reduce the food intake ([10](#B10), [110](#B110), [127](#B127)), potentially as a result of LCFA-CoA cytoplasmic accumulation.”

    From Mitochondrial fatty acid oxidation in obesity (2013) · cites this paper as [10]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Bentebibel, A., Sebastián, D., Herrero, L., López-Viñas, E., Serra, D., Asins, G., Gómez-Puertas, P., & Hegardt, F. G.
Affiliations
  • Consejo Superior de Investigaciones Científicas (ES)
  • Department of Biochemistry and Molecular Biology, School of Pharmacy, University of Barcelona, E-08028 Barcelona, Spain, and Centro de Biologia Molecular “Severo Ochoa”, Universidad Autonoma de Madrid, Consejo Superior de Investigaciones Científicas, Cantoblanco, E-28049 Madrid, Spain
Venue
Biochemistry
Published
2006-03-14
Volume
45
Issue
14
Pages
4339-4350
ISSN
  • 0006-2960 (ISSN-L)
  • 1520-4995
OpenAlex
W2102016174
Cited by
58
References
48
Citations by year
2026: 1 · 2025: 1 · 2024: 2 · 2023: 1 · 2022: 4 · 2021: 3 · 2020: 1 · 2019: 4 · 2018: 6 · 2017: 3 · 2016: 2 · 2015: 2 · 2014: 5 · 2013: 4 · 2012: 2
FWCI
1.55
Type
journal article
Language
en
Open access
closed
Locations
  • Biochemistry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
Keywords
C75, carnitine palmitoyltransferase 1, palmitate oxidation, fatty acid oxidation, fatty acid synthase inhibitors, obesity treatment, competitive inhibition, molecular docking, liver mitochondria, muscle mitochondria
MeSH terms
Acyl Coenzyme A, Animals, Carnitine O-Palmitoyltransferase, Cells, Cultured, Coenzyme A Ligases, Epoxy Compounds, Humans, Kinetics, Male, Mice, Inbred C57BL, Mitochondria, Liver, Mitochondria, Muscle, Oxidation-Reduction, 4-Butyrolactone, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Palmitic Acid, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review